Plasma Protein Forum 2025: From Anti-D Plasma and Blood Supply Incentives to the Future of AI
Plasma Protein Therapeutics Association (PPTA) shared on LinkedIn:
”The final day of the Plasma Protein Forum began with an informative keynote from Dr. Mario Macis of The Johns Hopkins University – Carey Business School, who provided research-driven perspectives on incentive-based behaviors and patterns, remarking that “Incentives can meaningfully and safely increase the blood supply.”
The following panel examined the lifesaving role of anti-D plasma with insights from patients, donors, and scientific and regulatory experts.
Patients-turned-donors shared their personal stories, moving the audience and inspiring applause.
Katie Shanahan of the The Allo Hope Foundation said that “It’s a bittersweet experience to pain into purpose.”
The day closed with an engaging discussion on AI in the plasma industry and broader health care.
Expert panelists shared case studies on technological innovations; Jan Hartmann, M.D. noted that “AI can help us optimize our efficiencies as organizations.”
In all, the conversations over the last few days sparked new ideas and reinforced the importance of advocacy, innovation, and collaboration.
A huge thank you to our speakers, sponsors, and all attendees for making PPF2025 a success.
Together, we’re advancing science, policy, and patient access around the world.”
More from PPF2025 featured in Hemostasis Today.
-
Mar 6, 2026, 16:51Priya Reehal: Highlighting The Central Role of Nurses in Cardio-Oncology
-
Mar 6, 2026, 16:50Rainer Kaiser: Blinatumomab Shows Remarkable Response in Multi-Refractory ITP and APS
-
Mar 6, 2026, 16:18Laila Shalabi: Clopidogrel, Aspirin, and the Role of PPIs in Coronary Artery Disease
-
Mar 6, 2026, 16:17Paul McKenzie: The Value of Gene Therapy in Bleeding Disorders
-
Mar 6, 2026, 16:15Basma El Homasany: The ‘Little Brain’ of the Heart and Its Role in Health
-
Mar 6, 2026, 16:14Jamal Rana: Family History and Polygenic Risk for Coronary Heart Disease
-
Mar 6, 2026, 15:43Kristy Ainslie: Breaking Down the Discovery and FDA Approval of Drug Carriers
-
Mar 6, 2026, 15:18Claudio Laudani: Efficacy and Safety of Colchicine for Secondary Prevention in Coronary Artery Disease
-
Mar 6, 2026, 15:09Chris Simon: Persona PLUS Receives FDA Clearance for Patent‑Protected Plasma Apheresis